Literature DB >> 26686633

T Cell Intrinsic USP15 Deficiency Promotes Excessive IFN-γ Production and an Immunosuppressive Tumor Microenvironment in MCA-Induced Fibrosarcoma.

Qiang Zou1, Jin Jin2, Yichuan Xiao3, Xiaofei Zhou4, Hongbo Hu5, Xuhong Cheng4, Nasser Kazimi4, Stephen E Ullrich6, Shao-Cong Sun7.   

Abstract

USP15 is a deubiquitinase that negatively regulates activation of naive CD4(+) T cells and generation of IFN-γ-producing T helper 1 (Th1) cells. USP15 deficiency in mice promotes antitumor T cell responses in a transplantable cancer model; however, it has remained unclear how deregulated T cell activation impacts primary tumor development during the prolonged interplay between tumors and the immune system. Here, we find that the USP15-deficient mice are hypersensitive to methylcholantrene (MCA)-induced fibrosarcomas. Excessive IFN-γ production in USP15-deficient mice promotes expression of the immunosuppressive molecule PD-L1 and the chemokine CXCL12, causing accumulation of T-bet(+) regulatory T cells and CD11b(+)Gr-1(+) myeloid-derived suppressor cells at tumor site. Mixed bone marrow adoptive transfer studies further reveals a T cell-intrinsic role for USP15 in regulating IFN-γ production and tumor development. These findings suggest that T cell intrinsic USP15 deficiency causes excessive production of IFN-γ, which promotes an immunosuppressive tumor microenvironment during MCA-induced primary tumorigenesis.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IFN-γ; T cells; USP15; immunosuppression; tumor microenvironment

Mesh:

Substances:

Year:  2015        PMID: 26686633      PMCID: PMC4691552          DOI: 10.1016/j.celrep.2015.11.046

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  32 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 2.  Paradoxical roles of the immune system during cancer development.

Authors:  Karin E de Visser; Alexandra Eichten; Lisa M Coussens
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

Review 3.  Interferons, immunity and cancer immunoediting.

Authors:  Gavin P Dunn; Catherine M Koebel; Robert D Schreiber
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

Review 4.  The two faces of interferon-γ in cancer.

Authors:  M Raza Zaidi; Glenn Merlino
Journal:  Clin Cancer Res       Date:  2011-06-24       Impact factor: 12.531

Review 5.  Immunosuppressive networks in the tumour environment and their therapeutic relevance.

Authors:  Weiping Zou
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

Review 6.  CD8+ T-cell memory in tumor immunology and immunotherapy.

Authors:  Christopher A Klebanoff; Luca Gattinoni; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

7.  Dual biological effects of the cytokines interleukin-10 and interferon-γ.

Authors:  Cailin Moira Wilke; Shuang Wei; Lin Wang; Ilona Kryczek; John Kao; Weiping Zou
Journal:  Cancer Immunol Immunother       Date:  2011-09-15       Impact factor: 6.968

8.  Tumor microenvironment and myeloid-derived suppressor cells.

Authors:  Viktor Umansky; Alexandra Sevko
Journal:  Cancer Microenviron       Date:  2012-12-16

9.  Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis.

Authors:  Jeremy B Swann; Matthew D Vesely; Anabel Silva; Janelle Sharkey; Shizuo Akira; Robert D Schreiber; Mark J Smyth
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-04       Impact factor: 11.205

Review 10.  The tumor microenvironment and its role in promoting tumor growth.

Authors:  T L Whiteside
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

View more
  19 in total

1.  Finding the 'ubiquitous' threads in infection and autoimmune neuroinflammation.

Authors:  Sophia Bardehle; Victoria Rafalski; Katerina Akassoglou
Journal:  Nat Immunol       Date:  2016-12-16       Impact factor: 25.606

2.  USP15 Deubiquitinates TUT1 Associated with RNA Metabolism and Maintains Cerebellar Homeostasis.

Authors:  Junnosuke Nakamura; Chiharu Hamada; Takumi Taketomi; Jaehyun Kim; Sarasa Yano; Tomomi Okajima; Shin-Ichi Kashiwabara; Tadashi Baba; Ban Sato; Tomoki Chiba; Fuminori Tsuruta
Journal:  Mol Cell Biol       Date:  2020-10-13       Impact factor: 4.272

3.  The Interferon-Gamma Paradox in Cancer.

Authors:  M Raza Zaidi
Journal:  J Interferon Cytokine Res       Date:  2018-11-09       Impact factor: 2.607

Review 4.  USP15: a review of its implication in immune and inflammatory processes and tumor progression.

Authors:  Anna Georges; Philippe Gros; Nassima Fodil
Journal:  Genes Immun       Date:  2021-04-06       Impact factor: 2.676

Review 5.  Role of Epigenetics in the Regulation of Immune Functions of the Skin.

Authors:  Yu Sawada; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2020-11-27       Impact factor: 8.551

Review 6.  Ubiquitin signaling in immune responses.

Authors:  Hongbo Hu; Shao-Cong Sun
Journal:  Cell Res       Date:  2016-03-25       Impact factor: 25.617

Review 7.  The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion.

Authors:  Marija Mojic; Kazuyoshi Takeda; Yoshihiro Hayakawa
Journal:  Int J Mol Sci       Date:  2017-12-28       Impact factor: 5.923

8.  IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting.

Authors:  Kazuyoshi Takeda; Masafumi Nakayama; Yoshihiro Hayakawa; Yuko Kojima; Hiroaki Ikeda; Naoko Imai; Kouetsu Ogasawara; Ko Okumura; David M Thomas; Mark J Smyth
Journal:  Nat Commun       Date:  2017-02-24       Impact factor: 14.919

9.  Association between B7-H1 and cervical cancer: B7-H1 impairs the immune response in human cervical cancer cells.

Authors:  Jianying Tao; Jianrong Dai; Shunyu Hou
Journal:  Exp Ther Med       Date:  2017-09-05       Impact factor: 2.447

10.  USP38 critically promotes asthmatic pathogenesis by stabilizing JunB protein.

Authors:  Siyuan Chen; Fenglin Yun; Yikun Yao; Mengtao Cao; Yifan Zhang; Jingjing Wang; Xinyang Song; Youcun Qian
Journal:  J Exp Med       Date:  2018-09-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.